Gene set | Source | Modules |
26S proteasome | GO | 28 91 |
3'\,5'-cyclic-nucleotide phosphodiesterase activity | Tissue | 560 |
A2058_1 | Tissue | 18 52 118 |
A2058_2 | Tissue | 18 52 118 |
acetylcholine receptor activity | GO | 216 267 328 415 |
acid-D-amino acid ligase activity | GO | 233 278 |
actin binding | GO | 419 524 |
actin filament-based movement | GO | 330 387 512 |
actin filament-based process | GO | 330 387 512 |
acyl-CoA dehydrogenase activity | GO | 184 221 |
adenylate cyclase activation | GO | 454 575 |
Adrenal_gland_1 | Tissue | 19 |
Adrenal_gland_2 | Tissue | 19 |
alcohol dehydrogenase activity | GO | 514 |
alcohol dehydrogenase activity\, zinc-dependent | Tissue | 514 |
aldehyde dehydrogenase activity | GO | 464 |
aldehyde metabolism | GO | 519 |
Alizadeh00 11 | Clusters | 238 301 361 436 |
Alizadeh00 13 | Clusters | 237 301 361 436 |
Alizadeh00 16 | Clusters | 97 182 261 358 525 |
Alizadeh00 18 | Clusters | 145 188 238 301 361 436 |
Alizadeh00 19 | Clusters | 169 |
Alizadeh00 20 | Clusters | 54 |
Alizadeh00 21 | Clusters | 495 |
Alizadeh00 23 | Clusters | 255 317 378 459 532 |
Alizadeh00 25 | Clusters | 79 128 170 |
Alizadeh00 27 | Clusters | 301 361 436 |
Alizadeh00 29 | Clusters | 128 170 |
Alizadeh00 30 | Clusters | 317 378 459 532 |
Alizadeh00 31 | Clusters | 429 484 |
Alizadeh00 33 | Clusters | 69 136 179 255 317 378 459 532 |
Alizadeh00 34 | Clusters | 378 459 532 |
Alizadeh00 36 | Clusters | 208 292 345 436 |
Alizadeh00 3 | Clusters | 136 179 255 317 378 459 532 |
Alizadeh00 40 | Clusters | 37 69 136 179 255 317 378 459 532 |
Alizadeh00 42 | Clusters | 61 126 |
Alizadeh00 43 | Clusters | 261 358 525 |
Alizadeh00 44 | Clusters | 534 |
Alizadeh00 45 | Clusters | 430 484 |
Alizadeh00 46 | Clusters | 456 |
Alizadeh00 48 | Clusters | 436 |
Alizadeh00 4 | Clusters | 179 255 317 378 459 532 |
Alizadeh00 5 | Clusters | 292 345 436 |
Alizadeh00 6 | Clusters | 277 358 525 |
Alizadeh00 8 | Clusters | 361 436 |
Alizadeh00 9 | Clusters | 182 261 358 525 |
alpha-type channel activity | GO | 316 415 |
amine metabolism | GO | 78 |
amine oxidase activity | GO | 557 |
amine receptor activity | GO | 383 441 |
amino acid activation | GO | 110 160 |
amino acid and derivative metabolism | GO | 78 |
amino acid biosynthesis | GO | 354 |
amino acid metabolism | GO | 235 |
Aminoacyl-tRNA_biosynthesis | KEGG | 133 160 |
Amygdala_1 | Tissue | 11 66 100 137 |
Amygdala_2 | Tissue | 11 66 100 137 |
Androgen_and_estrogen_metabolism | KEGG | 505 |
angiogenesis | GO | 178 362 444 516 |
anion transport | GO | 141 396 489 |
anti-apoptosis | GO | 537 |
antibacterial peptide activity | GO | 423 478 |
anticoagulant activity | GO | 328 415 |
antifungal peptide activity | GO | 423 478 |
antigen binding | GO | 522 |
antigen presentation\, endogenous antigen | Tissue | 144 293 345 436 |
antigen presentation\, peptide antigen | Tissue | 143 293 345 436 |
antigen processing\, endogenous antigen via MHC class I | Tissue | 144 293 345 436 |
antigen processing\, exogenous antigen via MHC class II | Tissue | 543 |
antigen processing | GO | 143 293 345 436 |
antimicrobial peptide activity | GO | 247 |
apoptosis inhibitor activity | GO | 537 |
apoptotic program | GO | 528 |
Apotosis | KEGG | 340 |
Armstrong01 11 | Clusters | 104 181 242 379 |
Armstrong01 12 | Clusters | 13 41 104 181 242 379 |
Armstrong01 13 | Clusters | 94 |
Armstrong01 21 | Clusters | 104 181 242 379 |
Armstrong01 22 | Clusters | 99 129 |
Armstrong01 25 | Clusters | 545 |
Armstrong01 26 | Clusters | 181 242 379 |
Armstrong01 27 | Clusters | 83 114 151 |
Armstrong01 29 | Clusters | 441 |
Armstrong01 31 | Clusters | 54 |
Armstrong01 32 | Clusters | 83 114 151 |
Armstrong01 34 | Clusters | 204 |
Armstrong01 37 | Clusters | 99 129 |
Armstrong01 38 | Clusters | 204 |
Armstrong01 39 | Clusters | 59 |
Armstrong01 40 | Clusters | 204 |
Armstrong01 42 | Clusters | 129 |
Armstrong01 44 | Clusters | 204 |
Armstrong01 47 | Clusters | 533 |
Armstrong01 48 | Clusters | 104 181 242 379 |
Armstrong01 4 | Clusters | 41 104 181 242 379 |
Armstrong01 5 | Clusters | 99 129 |
Armstrong01 6 | Clusters | 99 129 |
aromatic amino acid family metabolism | GO | 140 |
ATPase activity\, coupled | Tissue | 229 318 403 451 |
ATP binding | GO | 244 |
ATP synthesis coupled electron transport (sensu Eukarya) | GO | 25 77 152 |
ATP_Synthesis | KEGG | 116 152 |
Benzoate_degradation | KEGG | 303 403 451 |
Bhattacharjee01 11 | Clusters | 181 242 379 |
Bhattacharjee01 15 | Clusters | 448 |
Bhattacharjee01 16 | Clusters | 99 129 |
Bhattacharjee01 18 | Clusters | 181 242 379 |
Bhattacharjee01 19 | Clusters | 94 |
Bhattacharjee01 20 | Clusters | 83 114 151 |
Bhattacharjee01 22 | Clusters | 47 |
Bhattacharjee01 23 | Clusters | 104 181 242 379 |
Bhattacharjee01 24 | Clusters | 99 129 |
Bhattacharjee01 25 | Clusters | 104 181 242 379 |
Bhattacharjee01 38 | Clusters | 489 |
Bhattacharjee01 6 | Clusters | 99 129 |
Bhattacharjee01 7 | Clusters | 84 |
biogenic amine metabolism | GO | 440 |
Blader01 12 | Clusters | 323 |
Blader01 24 | Clusters | 495 |
Blader01 28 | Clusters | 495 |
Blader01 36 | Clusters | 495 |
Blader01 37 | Clusters | 495 |
Blader01 38 | Clusters | 495 |
Blader01 40 | Clusters | 458 |
Blader01 50 | Clusters | 151 |
blood coagulation | GO | 131 |
blood group antigen | GO | 539 |
Boldrick02 10 | Clusters | 119 171 208 292 345 436 |
Boldrick02 11 | Clusters | 358 525 |
Boldrick02 12 | Clusters | 126 |
Boldrick02 15 | Clusters | 37 69 136 179 255 317 378 459 532 |
Boldrick02 16 | Clusters | 126 |
Boldrick02 17 | Clusters | 179 255 317 378 459 532 |
Boldrick02 18 | Clusters | 171 208 292 345 436 |
Boldrick02 19 | Clusters | 481 544 |
Boldrick02 20 | Clusters | 69 136 179 255 317 378 459 532 |
Boldrick02 22 | Clusters | 308 |
Boldrick02 26 | Clusters | 481 544 |
Boldrick02 27 | Clusters | 136 179 255 317 378 459 532 |
Boldrick02 28 | Clusters | 126 |
Boldrick02 30 | Clusters | 522 |
Boldrick02 32 | Clusters | 308 |
Boldrick02 34 | Clusters | 229 318 403 451 |
Boldrick02 35 | Clusters | 532 |
Boldrick02 36 | Clusters | 119 171 208 292 345 436 |
Boldrick02 40 | Clusters | 465 560 |
Boldrick02 46 | Clusters | 317 378 459 532 |
Boldrick02 49 | Clusters | 261 358 525 |
Boldrick02 4 | Clusters | 171 208 292 345 436 |
Boldrick02 5 | Clusters | 372 441 |
Boldrick02 8 | Clusters | 255 317 378 459 532 |
Boldrick02 9 | Clusters | 119 171 208 292 345 436 |
bone remodeling | GO | 234 |
brain development | GO | 372 441 |
Burkitts_Daudi_1 | Tissue | 53 118 |
Burkitts_Daudi_2 | Tissue | 53 118 |
Burkitts_Raji_1 | Tissue | 53 118 |
Burkitts_Raji_2 | Tissue | 53 118 |
calcium-dependent phospholipid binding | GO | 390 543 |
calcium ion binding | GO | 324 |
calcium ion homeostasis | GO | 262 |
carbohydrate binding | GO | 96 410 |
carbohydrate metabolism | GO | 212 |
carbohydrate transporter activity | GO | 311 573 |
carbon-carbon lyase activity | GO | 272 377 |
Carbon_fixation | KEGG | 377 |
carbon-oxygen lyase activity | GO | 295 343 |
carboxylic acid biosynthesis | GO | 327 462 |
carboxylic acid catabolism | GO | 417 |
carboxylic acid metabolism | GO | 40 |
carboxylic acid transporter activity | GO | 71 186 341 411 511 |
carboxylic acid transport | GO | 71 186 341 411 511 |
carboxylic ester hydrolase activity | GO | 401 |
carboxypeptidase A activity | GO | 231 402 492 568 |
carboxypeptidase activity | GO | 402 492 568 |
catabolism | GO | 172 209 |
catalytic activity | GO | 212 |
cation homeostasis | GO | 191 262 |
cation transporter activity | GO | 307 |
cation transport | GO | 498 |
Caudate_nucleus_1 | Tissue | 11 66 100 137 |
Caudate_nucleus_2 | Tissue | 11 66 100 137 |
cbb3-type cytochrome c oxidase | GO | 103 152 |
cell adhesion | GO | 122 |
cell adhesion molecule activity | GO | 122 |
cell adhesion receptor activity | GO | 275 412 |
cell-cell signaling | GO | 92 |
cell cycle checkpoint | GO | 372 441 |
Cell cycle | GenMapp | 57 |
Cell_cycle | KEGG | 57 |
cell death | GO | 399 |
cell ion homeostasis | GO | 191 262 |
cell-matrix adhesion | GO | 412 |
cell migration | GO | 411 511 |
cellular morphogenesis | GO | 524 |
central nervous system development | GO | 497 |
Cerebellum_1 | Tissue | 11 66 100 137 |
Cerebellum_2 | Tissue | 11 66 100 137 |
cGMP biosynthesis | GO | 445 516 |
channel/pore class transporter activity | GO | 63 |
chaperone activity | GO | 299 355 |
chemokine receptor binding | GO | 263 |
chemosensory perception | GO | 123 197 252 |
chemotaxis | GO | 108 263 |
Chen02 11 | Clusters | 458 |
Chen02 13 | Clusters | 205 |
Chen02 14 | Clusters | 67 |
Chen02 19 | Clusters | 239 |
Chen02 1 | Clusters | 257 |
Chen02 27 | Clusters | 451 |
Chen02 2 | Clusters | 493 |
Chen02 33 | Clusters | 49 95 163 |
Chen02 47 | Clusters | 212 |
Chen02 50 | Clusters | 84 |
Chen02 6 | Clusters | 239 |
Chen02 8 | Clusters | 48 95 163 |
chloride transport | GO | 396 489 |
Cholesterol Biosynthesis | GenMapp | 432 |
cholesterol biosynthesis | GO | 432 |
cholesterol metabolism | GO | 236 |
chromatin assembly/disassembly | GO | 189 552 |
chromatin | GO | 552 |
chromatin remodeling complex | GO | 450 538 |
chromosome | GO | 168 222 421 534 |
chromosome organization and biogenesis (sensu Eukarya) | GO | 392 457 |
chymotrypsin activity | GO | 109 |
Citrate_cycle_TCA_cycle | KEGG | 306 |
clathrin vesicle coat | GO | 264 395 509 |
coated vesicle | GO | 39 264 395 509 |
collagen binding | GO | 513 |
collagen catabolism | GO | 211 562 |
complement activation\, classical pathway | Tissue | 58 130 |
Complement Activation, Classical Pathway | GenMapp | 130 |
complement activation | GO | 58 130 |
complement activity | GO | 130 |
compound eye morphogenesis (sensu Drosophila) | GO | 80 200 259 |
condensed chromosome | GO | 222 421 534 |
condensed nuclear chromosome kinetochore | GO | 421 534 |
conjugation with cellular fusion | GO | 573 |
conjugation without cellular fusion | GO | 289 375 |
Corpus_callosum_1 | Tissue | 11 66 100 137 |
Corpus_callosum_2 | Tissue | 11 66 100 137 |
Corpus_callosum_3 | Tissue | 11 66 100 137 |
Cortex | Tissue | 11 66 100 137 |
Cuadras02 22 | Clusters | 350 |
Cuadras02 33 | Clusters | 363 |
Cuadras02 35 | Clusters | 95 163 |
Cuadras02 48 | Clusters | 372 441 |
Cuadras02 9 | Clusters | 243 |
cyclic nucleotide biosynthesis | GO | 65 445 516 |
cyclic nucleotide metabolism | GO | 65 445 516 |
cysteine metabolism | GO | 428 471 528 |
Cysteine_metabolism | KEGG | 530 |
cytochrome c oxidase activity | GO | 103 152 |
cytochrome P450 activity | GO | 106 135 |
cytokine activity | GO | 433 |
cytolysis | GO | 575 |
Cytoplasmic Ribosomal Proteins | GenMapp | 83 114 151 |
Cytoplasmic tRNA Synthetases | GenMapp | 133 160 |
cytoskeletal protein binding | GO | 419 524 |
cytoskeleton-dependent intracellular transport | GO | 196 253 |
cytosolic calcium ion concentration elevation | GO | 288 375 |
cytosolic large ribosomal subunit (sensu Eukarya) | GO | 83 114 151 |
cytosolic small ribosomal subunit (sensu Eukarya) | GO | 29 83 114 151 |
damaged DNA binding | GO | 392 457 |
defense response | GO | 223 |
Detweiler01 13 | Clusters | 95 163 |
Detweiler01 19 | Clusters | 372 441 |
Detweiler01 20 | Clusters | 257 |
Detweiler01 23 | Clusters | 9 48 95 163 |
Detweiler01 24 | Clusters | 383 441 |
Detweiler01 27 | Clusters | 342 |
Detweiler01 29 | Clusters | 239 |
Detweiler01 36 | Clusters | 397 |
Detweiler01 41 | Clusters | 205 |
Detweiler01 49 | Clusters | 486 |
Detweiler01 8 | Clusters | 114 151 |
development | GO | 220 |
DNA binding | GO | 198 252 |
DNA dependent ATPase activity | GO | 318 403 451 |
DNA dependent DNA replication | GO | 125 158 |
DNA packaging | GO | 127 189 552 |
DNA replication and chromosome cycle | GO | 125 158 |
DNA replication | GO | 125 158 |
DOHH2_1 | Tissue | 53 118 |
DOHH2_2 | Tissue | 53 118 |
DRG_1 | Tissue | 2 |
DRG_2 | Tissue | 2 |
ectoderm development | GO | 153 297 357 |
eicosanoid biosynthesis | GO | 148 326 462 |
eicosanoid metabolism | GO | 148 326 462 |
Eicosanoid Synthesis | GenMapp | 431 |
Electron Transport Chain | GenMapp | 62 152 |
electron transporter activity | GO | 93 |
electron transport | GO | 43 |
embryonic development | GO | 14 178 362 444 516 |
embryonic pattern specification | GO | 14 178 362 444 516 |
endomembrane system | GO | 98 198 252 |
endonuclease activity | GO | 360 439 |
endopeptidase activity | GO | 209 |
endopeptidase inhibitor activity | GO | 164 |
endoribonuclease activity | GO | 467 |
energy derivation by oxidation of organic compounds | GO | 306 |
energy pathways | GO | 43 |
energy taxis | GO | 108 263 |
enzyme inhibitor activity | GO | 164 |
ephrin receptor activity | GO | 493 |
epidermal differentiation | GO | 153 297 357 |
establishment and/or maintenance of chromatin architecture | GO | 127 189 552 |
eukaryotic 43S pre-initiation complex | GO | 149 |
eukaryotic translation initiation factor 3 complex | GO | 447 |
excitatory extracellular ligand-gated ion channel activity | GO | 267 328 415 |
excretion | GO | 416 |
extracellular ligand-gated ion channel activity | GO | 214 |
extracellular matrix structural constituent | GO | 122 |
eye photoreceptor cell fate commitment | GO | 80 200 259 |
fatty acid beta-oxidation | GO | 185 221 |
fatty acid biosynthesis | GO | 326 462 |
Fatty Acid Degradation | GenMapp | 184 221 |
fatty acid oxidation | GO | 185 221 |
Fc receptor activity | GO | 424 478 |
Fetal_brain_1 | Tissue | 11 66 100 137 |
Fetal_brain_2 | Tissue | 11 66 100 137 |
Fetal_liver_1 | Tissue | 24 55 88 |
Fetal_liver_2 | Tissue | 24 55 88 |
fibrillar collagen | GO | 513 |
GA10_1 | Tissue | 53 118 |
GA10_2 | Tissue | 53 118 |
GABA-A receptor activity | GO | 215 |
galactose binding | GO | 391 543 |
gap-junction forming channel activity | GO | 482 544 |
gap junction | GO | 482 544 |
Garber01 10 | Clusters | 49 95 163 |
Garber01 19 | Clusters | 67 |
Garber01 20 | Clusters | 486 |
Garber01 23 | Clusters | 54 |
Garber01 28 | Clusters | 441 |
Garber01 30 | Clusters | 534 |
Garber01 31 | Clusters | 47 |
Garber01 35 | Clusters | 312 439 |
Garber01 43 | Clusters | 83 114 151 |
Garber01 45 | Clusters | 84 |
Garber01 48 | Clusters | 372 441 |
Garber01 49 | Clusters | 95 163 |
Garber01 4 | Clusters | 154 297 357 |
Garber01 50 | Clusters | 205 |
glutathione conjugation reaction | GO | 101 132 310 |
Glutathione_metabolism | KEGG | 310 |
glutathione peroxidase activity | GO | 530 |
glutathione transferase activity | GO | 101 132 310 |
Glycerolipid_metabolism | KEGG | 557 |
Glycolysis and Gluconeogenesis | GenMapp | 377 |
glycolysis | GO | 306 |
glycosaminoglycan binding | GO | 385 |
glycosaminoglycan metabolism | GO | 509 |
Golub99 11 | Clusters | 20 111 157 242 379 |
Golub99 12 | Clusters | 120 175 241 291 |
Golub99 15 | Clusters | 105 |
Golub99 17 | Clusters | 83 114 151 |
Golub99 18 | Clusters | 111 157 242 379 |
Golub99 19 | Clusters | 120 175 241 291 |
Golub99 1 | Clusters | 120 175 241 291 |
Golub99 23 | Clusters | 112 176 |
Golub99 24 | Clusters | 175 241 291 |
Golub99 30 | Clusters | 175 241 291 |
Golub99 31 | Clusters | 111 157 242 379 |
Golub99 32 | Clusters | 33 |
Golub99 41 | Clusters | 120 175 241 291 |
Golub99 42 | Clusters | 120 175 241 291 |
Golub99 43 | Clusters | 120 175 241 291 |
Golub99 44 | Clusters | 157 242 379 |
Golub99 45 | Clusters | 204 |
Golub99 46 | Clusters | 400 |
Golub99 48 | Clusters | 111 157 242 379 |
Golub99 49 | Clusters | 113 176 |
Golub99 7 | Clusters | 151 |
Golub99 8 | Clusters | 501 |
GPCRs, Class A Rhodopsin-like 2 | GenMapp | 571 |
GPCRs, Class B Secretin-like | GenMapp | 470 557 |
GPCRs, Class C Metabotropic glutamate, pheromone | GenMapp | 493 |
GPI-anchored membrane-bound receptor | GO | 328 415 |
G-protein chemoattractant receptor activity | GO | 288 375 |
G-protein coupled receptor activity | GO | 146 |
G-protein coupled receptor protein signaling pathway | GO | 289 375 |
G-protein signaling\, adenylate cyclase activating pathway | Tissue | 454 575 |
G-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | Tissue | 367 |
growth factor activity | GO | 433 |
growth factor binding | GO | 190 474 |
GTPase activity | GO | 86 |
GTP binding | GO | 87 |
guanylate cyclase activity | GO | 445 516 |
Heart_1 | Tissue | 60 88 |
Heart_2 | Tissue | 60 88 |
heat shock protein activity | GO | 355 |
hematopoietin/interferon-class (D200-domain) cytokine receptor activity | GO | 265 |
Heme Biosynthesis | GenMapp | 227 539 |
heme biosynthesis | GO | 335 505 |
hemostasis | GO | 131 |
Hep3b_1 | Tissue | 8 52 118 |
Hep3b_2 | Tissue | 8 52 118 |
heparin binding | GO | 385 |
heterocycle metabolism | GO | 376 450 538 |
heterophilic cell adhesion | GO | 410 |
hexosaminidase activity | GO | 408 491 568 |
Histidine_metabolism | KEGG | 373 |
histogenesis | GO | 153 297 357 |
HL60_1 | Tissue | 16 53 118 |
HL60_2 | Tissue | 16 53 118 |
hormone activity | GO | 382 |
hormone metabolism | GO | 445 516 |
host-pathogen interaction | GO | 254 312 439 |
humoral immune response | GO | 75 |
HUVEC_1 | Tissue | 52 118 |
HUVEC_2 | Tissue | 3 52 118 |
HUVEC_3 | Tissue | 3 52 118 |
hydrogen-exporting ATPase activity\, phosphorylative mechanism | Tissue | 402 492 568 |
hydrogen ion transporter activity | GO | 62 152 |
hydrolase activity | GO | 151 |
hydrolase activity\, hydrolyzing O-glycosyl compounds | Tissue | 492 568 |
hydro-lyase activity | GO | 295 343 |
immune response | GO | 46 75 |
immunoglobulin receptor activity | GO | 424 478 |
induction of programmed cell death | GO | 300 399 |
inflammatory response | GO | 76 |
inner membrane | GO | 62 152 |
inorganic anion transport | GO | 141 396 489 |
inositol/phosphatidylinositol kinase activity | GO | 421 534 |
inotropic glutamate receptor activity | GO | 498 |
insulin-like growth factor binding | GO | 190 474 |
integral to plasma membrane | GO | 64 |
integrin complex | GO | 275 412 |
integrin-mediated signaling pathway | GO | 275 412 |
interleukin-1 receptor activity | GO | 496 545 |
interleukin-1\, Type I\, activating receptor activity | Tissue | 496 545 |
interleukin binding | GO | 73 265 |
interleukin receptor activity | GO | 73 265 |
intermediate filament | GO | 68 298 357 |
intracellular transport | GO | 196 253 |
ion channel activity | GO | 316 415 |
ion transporter activity | GO | 62 152 |
ion transport | GO | 316 415 |
iron ion homeostasis | GO | 540 |
Iyer99 14 | Clusters | 447 |
Iyer99 15 | Clusters | 511 |
Iyer99 17 | Clusters | 54 |
Iyer99 31 | Clusters | 151 |
Iyer99 34 | Clusters | 418 455 |
Iyer99 44 | Clusters | 372 441 |
Iyer99 4 | Clusters | 418 455 |
Iyer99 9 | Clusters | 426 |
K422_1 | Tissue | 53 118 |
K422_2 | Tissue | 53 118 |
Kidney_1 | Tissue | 55 88 |
Kidney_2 | Tissue | 55 88 |
Kidney_3 | Tissue | 55 88 |
kinase activity | GO | 160 |
kinesin complex | GO | 438 533 |
kinetochore | GO | 315 |
large ribosomal subunit | GO | 83 114 151 |
Lessnick02 15 | Clusters | 104 181 242 379 |
Lessnick02 18 | Clusters | 340 |
Lessnick02 20 | Clusters | 54 |
Lessnick02 25 | Clusters | 13 41 104 181 242 379 |
Lessnick02 26 | Clusters | 181 242 379 |
Lessnick02 36 | Clusters | 104 181 242 379 |
Lessnick02 38 | Clusters | 117 |
Lessnick02 3 | Clusters | 104 181 242 379 |
Lessnick02 48 | Clusters | 379 |
Lessnick02 4 | Clusters | 83 114 151 |
leukotriene biosynthesis | GO | 326 462 |
ligand-gated ion channel activity | GO | 214 |
ligase activity\, forming aminoacyl-tRNA and related compounds | Tissue | 35 110 160 |
ligase activity\, forming carbon-nitrogen bonds | Tissue | 278 |
ligase activity\, forming phosphoric ester bonds | Tissue | 35 110 160 |
lipase activity | GO | 401 |
lipid catabolism | GO | 417 |
lipoprotein binding | GO | 557 |
lipoprotein biosynthesis | GO | 236 |
Liver_1 | Tissue | 23 55 88 |
Liver_2 | Tissue | 23 55 88 |
Lung_1 | Tissue | 5 |
Lung_2 | Tissue | 5 |
Lymphoblastic_molt-4_1 | Tissue | 53 118 |
Lymphoblastic_molt-4_2 | Tissue | 53 118 |
Lymphoblastic_molt-4_3 | Tissue | 53 118 |
lymphocyte activation | GO | 121 223 |
lymphocyte antigen | GO | 501 |
lymphocyte proliferation | GO | 521 |
Lysine_degradation | KEGG | 305 |
macromolecule catabolism | GO | 211 562 |
magnesium ion binding | GO | 471 528 |
main pathways of carbohydrate metabolism | GO | 306 |
MAPKKK cascade | GO | 173 407 465 560 |
MAPKKK cascade (osmolarity sensing) | GO | 407 465 560 |
Matrix Metalloproteinases | GenMapp | 562 |
membrane lipid catabolism | GO | 260 346 408 491 568 |
membrane lipid metabolism | GO | 346 408 491 568 |
mesoderm development | GO | 400 |
metal ion binding | GO | 324 |
metal ion homeostasis | GO | 191 262 |
metal ion transporter activity | GO | 22 62 152 |
metallocarboxypeptidase activity | GO | 231 402 492 568 |
metalloendopeptidase activity | GO | 210 562 |
metallopeptidase activity | GO | 210 562 |
methyltransferase activity | GO | 349 |
MHC class I receptor activity | GO | 144 293 345 436 |
microtubule associated complex | GO | 438 533 |
microtubule-based process | GO | 253 |
microtubule cytoskeleton | GO | 438 533 |
microtubule | GO | 395 509 |
mitochondrial electron transport\, NADH to ubiquinone | Tissue | 25 77 152 |
mitochondrial inner membrane | GO | 152 |
mitochondrial membrane | GO | 62 152 |
mitochondrion | GO | 152 |
mitotic anaphase | GO | 397 |
mitotic checkpoint | GO | 315 |
Monoamine GPCRs | GenMapp | 372 441 |
monocarboxylic acid transporter activity | GO | 0 71 186 341 411 511 |
monocarboxylic acid transport | GO | 0 71 186 341 411 511 |
monosaccharide binding | GO | 391 543 |
monovalent inorganic cation transporter activity | GO | 62 152 |
morphogenesis | GO | 220 |
motor activity | GO | 196 253 |
M phase | GO | 320 397 |
M phase of mitotic cell cycle | GO | 320 397 |
mRNA binding | GO | 183 |
mRNA processing | GO | 332 |
mRNA splicing | GO | 183 |
muscle contraction | GO | 201 329 387 512 |
muscle development | GO | 329 387 512 |
muscle fiber | GO | 202 329 387 512 |
Myelogenous_k-562_1 | Tissue | 17 52 118 |
Myelogenous_k-562_2 | Tissue | 17 52 118 |
NADH dehydrogenase activity | GO | 42 77 152 |
NADH dehydrogenase (ubiquinone) activity | GO | 42 77 152 |
negative regulation of cell proliferation | GO | 488 |
neurotransmitter receptor activity | GO | 215 |
neurotransmitter secretion | GO | 563 |
Nicotinate_and_nicotinamide_metabolism | KEGG | 303 403 451 |
nicotinic acetylcholine-activated cation-selective channel activity | GO | 216 267 328 415 |
nicotinic acetylcholine-gated receptor-channel complex | GO | 216 267 328 415 |
Nitrogen_metabolism | KEGG | 294 343 |
nuclear chromatin | GO | 89 203 552 |
nuclear chromosome | GO | 168 222 421 534 |
nuclear division | GO | 320 397 |
nuclear lamina | GO | 68 298 357 |
nuclear membrane | GO | 298 357 |
nuclear pore | GO | 352 |
nuclease activity | GO | 32 83 114 151 |
nucleic acid binding | GO | 32 83 114 151 |
nucleobase metabolism | GO | 376 450 538 |
nucleolar preribosome | GO | 525 |
nucleolus | GO | 392 457 |
nucleoside monophosphate biosynthesis | GO | 21 56 102 219 |
nucleoside monophosphate phosphorylation | GO | 116 152 |
nucleosome assembly | GO | 90 203 552 |
nucleosome disassembly | GO | 90 203 552 |
nucleotide binding | GO | 538 |
nucleotide biosynthesis | GO | 102 219 |
Nucleotide Metabolism | GenMapp | 337 397 |
nucleotide metabolism | GO | 219 |
nucleotide receptor activity | GO | 328 415 |
nucleotidyltransferase activity | GO | 244 |
nucleus | GO | 98 198 252 |
Nutt03 10 | Clusters | 501 |
Nutt03 14 | Clusters | 36 |
Nutt03 15 | Clusters | 83 114 151 |
Nutt03 16 | Clusters | 137 |
Nutt03 18 | Clusters | 400 |
Nutt03 23 | Clusters | 137 |
Nutt03 26 | Clusters | 66 100 137 |
Nutt03 36 | Clusters | 41 104 181 242 379 |
Nutt03 38 | Clusters | 104 181 242 379 |
Nutt03 41 | Clusters | 41 104 181 242 379 |
Nutt03 43 | Clusters | 13 41 104 181 242 379 |
Nutt03 44 | Clusters | 117 |
organellar ribosome | GO | 377 |
organic acid biosynthesis | GO | 327 462 |
organic acid metabolism | GO | 40 |
organic acid transporter activity | GO | 71 186 341 411 511 |
organic acid transport | GO | 186 341 411 511 |
organogenesis | GO | 220 |
ossification | GO | 400 |
Ovary_2 | Tissue | 1 |
Ovary_3 | Tissue | 1 |
oxidative phosphorylation | GO | 77 152 |
Oxidative_phosphorylation | KEGG | 62 152 |
oxidoreductase activity\, acting on CH-OH group of donors | Tissue | 286 |
oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen\, 2-oxoglutarate as one donor\, and incorporation of one atom each of oxygen into both donors | Tissue | 423 478 |
oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen | Tissue | 135 |
oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen\, reduced flavin or flavoprotein as one donor\, and incorporation of one atom of oxygen | Tissue | 106 135 |
oxidoreductase activity\, acting on single donors with incorporation of molecular oxygen | Tissue | 423 478 |
oxidoreductase activity\, acting on the aldehyde or oxo group of donors\, NAD or NADP as acceptor | Tissue | 194 464 |
oxidoreductase activity\, acting on the aldehyde or oxo group of donors | Tissue | 194 464 |
oxidoreductase activity\, acting on the CH-CH group of donors\, other acceptors | Tissue | 294 343 |
oxidoreductase activity\, acting on the CH-CH group of donors | Tissue | 184 221 |
oxidoreductase activity\, acting on the CH-NH2 group of donors | Tissue | 373 |
oxidoreductase activity\, acting on the CH-NH group of donors\, NAD or NADP as acceptor | Tissue | 224 272 377 |
oxidoreductase activity\, acting on the CH-NH group of donors | Tissue | 224 272 377 |
oxidoreductase activity\, acting on the CH-OH group of donors\, NAD or NADP as acceptor | Tissue | 286 |
oxidoreductase activity | GO | 93 |
oxygen and reactive oxygen species metabolism | GO | 132 310 |
Pancreas_1 | Tissue | 55 88 |
Pancreas_2 | Tissue | 55 88 |
pancreatic ribonuclease activity | GO | 467 |
pathogenesis | GO | 501 |
pattern specification | GO | 362 444 516 |
peptidase activity | GO | 209 |
peptide binding | GO | 155 245 299 355 |
Peptide GPCRs | GenMapp | 288 375 |
peptide hormone | GO | 382 |
peptide receptor activity | GO | 134 288 375 |
peptide receptor activity\, G-protein coupled | Tissue | 134 288 375 |
peptide transporter activity | GO | 162 218 368 511 |
perception of light | GO | 287 373 |
perception of mechanical stimulus | GO | 571 |
peripheral nervous system development | GO | 560 |
Perou00 13 | Clusters | 342 |
Perou00 17 | Clusters | 389 |
Perou00 18 | Clusters | 84 |
Perou00 22 | Clusters | 83 114 151 |
Perou00 25 | Clusters | 239 |
Perou00 28 | Clusters | 321 |
Perou00 29 | Clusters | 345 436 |
Perou00 2 | Clusters | 139 180 342 |
Perou00 31 | Clusters | 47 |
Perou00 34 | Clusters | 26 207 389 |
Perou00 35 | Clusters | 207 389 |
Perou00 36 | Clusters | 207 389 |
Perou00 39 | Clusters | 206 389 |
Perou00 40 | Clusters | 239 |
Perou00 41 | Clusters | 154 297 357 |
Perou00 42 | Clusters | 84 |
Perou00 43 | Clusters | 321 |
Perou00 45 | Clusters | 403 451 |
Perou00 46 | Clusters | 207 389 |
Perou00 49 | Clusters | 372 441 |
Perou00 6 | Clusters | 54 |
Perou00 7 | Clusters | 448 |
Perou99 10 | Clusters | 333 427 480 |
Perou99 11 | Clusters | 192 279 334 427 480 |
Perou99 13 | Clusters | 156 240 313 547 |
Perou99 14 | Clusters | 279 334 427 480 |
Perou99 15 | Clusters | 192 279 334 427 480 |
Perou99 17 | Clusters | 156 240 313 547 |
Perou99 18 | Clusters | 313 547 |
Perou99 1 | Clusters | 503 576 |
Perou99 20 | Clusters | 156 240 313 547 |
Perou99 21 | Clusters | 503 576 |
Perou99 22 | Clusters | 333 427 480 |
Perou99 23 | Clusters | 503 576 |
Perou99 24 | Clusters | 147 195 356 503 576 |
Perou99 25 | Clusters | 195 356 503 576 |
Perou99 26 | Clusters | 240 313 547 |
Perou99 27 | Clusters | 156 240 313 547 |
Perou99 28 | Clusters | 333 427 480 |
Perou99 29 | Clusters | 166 256 333 427 480 |
Perou99 2 | Clusters | 166 256 333 427 480 |
Perou99 31 | Clusters | 333 427 480 |
Perou99 33 | Clusters | 256 333 427 480 |
Perou99 35 | Clusters | 156 240 313 547 |
Perou99 36 | Clusters | 356 503 576 |
Perou99 37 | Clusters | 147 195 356 503 576 |
Perou99 38 | Clusters | 480 |
Perou99 39 | Clusters | 447 |
Perou99 3 | Clusters | 156 240 313 547 |
Perou99 41 | Clusters | 156 240 313 547 |
Perou99 42 | Clusters | 547 |
Perou99 43 | Clusters | 156 240 313 547 |
Perou99 44 | Clusters | 192 279 334 427 480 |
Perou99 45 | Clusters | 240 313 547 |
Perou99 47 | Clusters | 576 |
Perou99 48 | Clusters | 421 534 |
Perou99 49 | Clusters | 256 333 427 480 |
Perou99 4 | Clusters | 156 240 313 547 |
Perou99 5 | Clusters | 156 240 313 547 |
Perou99 6 | Clusters | 547 |
Perou99 7 | Clusters | 439 |
Perou99 8 | Clusters | 334 427 480 |
Perou99 9 | Clusters | 503 576 |
phenylalanine catabolism | GO | 140 |
phenylalanine metabolism | GO | 140 |
phosphatase regulator activity | GO | 226 281 371 |
phosphate metabolism | GO | 273 363 |
phospholipase inhibitor activity | GO | 390 543 |
phospholipid binding | GO | 414 |
phosphoric ester hydrolase activity | GO | 534 |
phosphorus metabolism | GO | 273 363 |
photosynthesis | GO | 43 |
photosynthesis\, light reaction | Tissue | 43 |
pigmentation | GO | 335 505 |
pigment biosynthesis | GO | 335 505 |
Pituitary_gland | Tissue | 66 100 137 |
Placenta_1 | Tissue | 38 |
Placenta_2 | Tissue | 38 |
Pollack99 10 | Clusters | 495 |
Pollack99 13 | Clusters | 533 |
Pollack99 22 | Clusters | 457 |
Pollack99 23 | Clusters | 485 |
Pollack99 27 | Clusters | 325 485 |
Pollack99 29 | Clusters | 243 |
Pollack99 32 | Clusters | 439 |
Pollack99 35 | Clusters | 342 |
Pollack99 44 | Clusters | 325 485 |
polysaccharide transporter activity | GO | 311 573 |
Pomeroy02 10 | Clusters | 111 157 242 379 |
Pomeroy02 12 | Clusters | 416 |
Pomeroy02 13 | Clusters | 111 157 242 379 |
Pomeroy02 14 | Clusters | 83 114 151 |
Pomeroy02 16 | Clusters | 500 |
Pomeroy02 20 | Clusters | 176 |
Pomeroy02 21 | Clusters | 138 174 241 291 |
Pomeroy02 31 | Clusters | 66 100 137 |
Pomeroy02 32 | Clusters | 100 137 |
Pomeroy02 36 | Clusters | 291 |
Pomeroy02 40 | Clusters | 157 242 379 |
Pomeroy02 41 | Clusters | 176 |
Pomeroy02 46 | Clusters | 497 |
Pomeroy02 49 | Clusters | 111 157 242 379 |
Pomeroy02 9 | Clusters | 113 176 |
pore complex | GO | 352 |
porin activity | GO | 63 |
Porphyrin_and_chlorophyll_metabolism | KEGG | 227 539 |
porter activity | GO | 368 511 |
positive regulation of cell proliferation | GO | 521 |
post-embryonic development | GO | 51 80 200 259 |
post-embryonic morphogenesis | GO | 51 80 200 259 |
potassium channel activity | GO | 498 |
potassium ion transport | GO | 498 |
P-P-bond-hydrolysis-driven transporter activity | GO | 283 337 397 |
pre-mRNA splicing factor activity | GO | 183 |
primary active transporter activity | GO | 283 337 397 |
programmed cell death | GO | 300 399 |
Propanoate_metabolism | KEGG | 184 221 |
Prostaglandin_and_leukotriene_metabolism | KEGG | 431 |
proteasome complex (sensu Eukarya) | GO | 91 |
proteasome core complex (sensu Eukarya) | GO | 50 91 |
Proteasome Degradation | GenMapp | 91 |
proteasome endopeptidase activity | GO | 50 91 |
Proteasome | KEGG | 28 91 |
protein amino acid dephosphorylation | GO | 498 |
protein biosynthesis | GO | 83 114 151 |
protein catabolism | GO | 211 562 |
protein disulfide oxidoreductase activity | GO | 519 |
protein-disulfide reduction | GO | 25 77 152 |
Protein_export | KEGG | 149 |
protein folding | GO | 155 245 299 355 |
protein kinase activity | GO | 199 259 |
protein phosphatase regulator activity | GO | 226 281 371 |
protein phosphatase type 2A activity | GO | 233 278 |
proteolysis and peptidolysis | GO | 107 172 209 |
proton-dependent oligopeptide transporter activity | GO | 162 218 368 511 |
proton transport | GO | 116 152 |
proton-transporting ATP synthase complex (sensu Eukarya) | GO | 414 |
Purine_metabolism | KEGG | 219 |
purine nucleoside monophosphate biosynthesis | GO | 31 56 102 219 |
purine nucleotide biosynthesis | GO | 219 |
purine ribonucleoside monophosphate biosynthesis | GO | 56 102 219 |
purine ribonucleoside monophosphate metabolism | GO | 31 56 102 219 |
purine ribonucleotide biosynthesis | GO | 102 219 |
Pyrimidine_metabolism | KEGG | 337 397 |
Ramaswamy01 10 | Clusters | 165 |
Ramaswamy01 12 | Clusters | 165 |
Ramaswamy01 15 | Clusters | 165 |
Ramaswamy01 18 | Clusters | 111 157 242 379 |
Ramaswamy01 22 | Clusters | 112 176 |
Ramaswamy01 25 | Clusters | 383 441 |
Ramaswamy01 26 | Clusters | 165 |
Ramaswamy01 28 | Clusters | 105 |
Ramaswamy01 29 | Clusters | 322 379 |
Ramaswamy01 32 | Clusters | 165 |
Ramaswamy01 33 | Clusters | 83 114 151 |
Ramaswamy01 34 | Clusters | 165 |
Ramaswamy01 35 | Clusters | 418 455 |
Ramaswamy01 36 | Clusters | 165 |
Ramaswamy01 37 | Clusters | 165 |
Ramaswamy01 38 | Clusters | 165 |
Ramaswamy01 3 | Clusters | 177 |
Ramaswamy01 40 | Clusters | 242 379 |
Ramaswamy01 41 | Clusters | 322 379 |
Ramaswamy01 44 | Clusters | 112 176 |
Ramaswamy01 48 | Clusters | 567 |
Ramaswamy01 4 | Clusters | 112 176 |
Ramaswamy01 5 | Clusters | 165 |
Ramaswamy01 6 | Clusters | 20 111 157 242 379 |
Ramaswamy01 8 | Clusters | 111 157 242 379 |
Ramos_1 | Tissue | 53 118 |
Ramos_2 | Tissue | 53 118 |
receptor activity | GO | 27 64 |
Reductive_carboxylate_cycle_CO2_fixation | KEGG | 305 |
regulation of catabolism | GO | 107 172 209 |
regulation of cell adhesion | GO | 444 516 |
regulation of cell growth | GO | 474 |
regulation of cell proliferation | GO | 488 |
regulation of complement activation | GO | 58 130 |
regulation of neurotransmitter levels | GO | 563 |
regulation of T-cell proliferation | GO | 521 |
regulation of transcription by pheromones | GO | 229 318 403 451 |
regulation of transcription\, DNA-dependent | Tissue | 197 252 |
regulation of translational initiation | GO | 81 115 149 |
replication fork | GO | 158 |
response to biotic stimulus | GO | 46 75 |
response to DNA damage stimulus | GO | 403 451 |
response to light | GO | 248 |
response to oxidative stress | GO | 530 |
response to pest/pathogen/parasite | GO | 75 |
response to radiation | GO | 248 |
response to stress | GO | 75 |
rhodopsin-like receptor activity | GO | 146 |
rhodopsin mediated phototransduction | GO | 251 367 |
rhodopsin mediated signaling | GO | 251 367 |
ribonuclease activity | GO | 360 439 |
ribonucleoprotein complex | GO | 83 114 151 |
ribonucleoside monophosphate biosynthesis | GO | 56 102 219 |
ribonucleoside monophosphate metabolism | GO | 21 56 102 219 |
ribonucleotide biosynthesis | GO | 102 219 |
ribonucleotide metabolism | GO | 219 |
ribosome | GO | 83 114 151 |
Ribosome | KEGG | 83 114 151 |
RNA binding | GO | 32 83 114 151 |
RNA metabolism | GO | 183 |
RNA processing | GO | 183 |
RNA splicing | GO | 183 |
Rosenwald01 11 | Clusters | 292 345 436 |
Rosenwald01 13 | Clusters | 525 |
Rosenwald01 14 | Clusters | 292 345 436 |
Rosenwald01 16 | Clusters | 429 484 |
Rosenwald01 17 | Clusters | 350 |
Rosenwald01 18 | Clusters | 136 179 255 317 378 459 532 |
Rosenwald01 19 | Clusters | 97 182 261 358 525 |
Rosenwald01 1 | Clusters | 136 179 255 317 378 459 532 |
Rosenwald01 22 | Clusters | 430 484 |
Rosenwald01 24 | Clusters | 69 136 179 255 317 378 459 532 |
Rosenwald01 25 | Clusters | 456 |
Rosenwald01 26 | Clusters | 459 532 |
Rosenwald01 27 | Clusters | 255 317 378 459 532 |
Rosenwald01 31 | Clusters | 188 238 301 361 436 |
Rosenwald01 32 | Clusters | 37 69 136 179 255 317 378 459 532 |
Rosenwald01 33 | Clusters | 97 182 261 358 525 |
Rosenwald01 34 | Clusters | 170 |
Rosenwald01 36 | Clusters | 169 |
Rosenwald01 38 | Clusters | 456 |
Rosenwald01 39 | Clusters | 277 358 525 |
Rosenwald01 3 | Clusters | 261 358 525 |
Rosenwald01 40 | Clusters | 238 301 361 436 |
Rosenwald01 42 | Clusters | 237 301 361 436 |
Rosenwald01 43 | Clusters | 525 |
Rosenwald01 45 | Clusters | 61 126 |
Rosenwald01 46 | Clusters | 54 |
Rosenwald01 48 | Clusters | 238 301 361 436 |
Rosenwald01 4 | Clusters | 456 |
Rosenwald01 50 | Clusters | 436 |
Rosenwald01 6 | Clusters | 79 128 170 |
Rosenwald01 8 | Clusters | 500 |
Rosenwald01 9 | Clusters | 145 188 238 301 361 436 |
Ross00 10 | Clusters | 491 568 |
Ross00 12 | Clusters | 491 568 |
Ross00 15 | Clusters | 342 |
Ross00 18 | Clusters | 332 |
Ross00 20 | Clusters | 180 342 |
Ross00 23 | Clusters | 151 |
Ross00 2 | Clusters | 418 455 |
Ross00 3 | Clusters | 180 342 |
Ross00 40 | Clusters | 455 |
Ross00 44 | Clusters | 331 |
Ross00 47 | Clusters | 525 |
Ross00 50 | Clusters | 321 |
Ross01 10 | Clusters | 372 441 |
Ross01 12 | Clusters | 342 |
Ross01 14 | Clusters | 342 |
Ross01 17 | Clusters | 389 |
Ross01 19 | Clusters | 151 |
Ross01 2 | Clusters | 337 397 |
Ross01 30 | Clusters | 485 |
Ross01 35 | Clusters | 139 180 342 |
Ross01 36 | Clusters | 207 389 |
Ross01 39 | Clusters | 154 297 357 |
Ross01 43 | Clusters | 372 441 |
Ross01 46 | Clusters | 341 411 511 |
Ross01 49 | Clusters | 331 |
Ross01 7 | Clusters | 47 |
Ross01 8 | Clusters | 342 |
rRNA processing | GO | 392 457 |
Salivary_gland_1 | Tissue | 88 |
Salivary_gland_2 | Tissue | 55 88 |
sarcomere | GO | 202 329 387 512 |
secretin-like receptor activity | GO | 470 557 |
secretion | GO | 92 |
secretory vesicle | GO | 563 |
sensory perception | GO | 123 197 252 |
serine protease inhibitor activity | GO | 164 |
serotonin metabolism | GO | 563 |
Shipp02 10 | Clusters | 112 176 |
Shipp02 11 | Clusters | 113 176 |
Shipp02 12 | Clusters | 138 174 241 291 |
Shipp02 13 | Clusters | 83 114 151 |
Shipp02 16 | Clusters | 372 441 |
Shipp02 20 | Clusters | 111 157 242 379 |
Shipp02 23 | Clusters | 112 176 |
Shipp02 25 | Clusters | 532 |
Shipp02 26 | Clusters | 177 |
Shipp02 27 | Clusters | 138 174 241 291 |
Shipp02 28 | Clusters | 105 |
Shipp02 2 | Clusters | 340 |
Shipp02 31 | Clusters | 379 |
Shipp02 32 | Clusters | 70 138 174 241 291 |
Shipp02 35 | Clusters | 176 |
Shipp02 37 | Clusters | 174 241 291 |
Shipp02 41 | Clusters | 157 242 379 |
Shipp02 42 | Clusters | 111 157 242 379 |
Shipp02 43 | Clusters | 242 379 |
Shipp02 45 | Clusters | 70 138 174 241 291 |
Shipp02 47 | Clusters | 20 111 157 242 379 |
Shipp02 4 | Clusters | 426 |
Shipp02 5 | Clusters | 105 |
Shipp02 8 | Clusters | 33 |
Shipp02 9 | Clusters | 112 176 |
signal sequence binding | GO | 245 299 355 |
signal transducer activity | GO | 64 |
Singh02 10 | Clusters | 7 41 104 181 242 379 |
Singh02 12 | Clusters | 41 104 181 242 379 |
Singh02 13 | Clusters | 13 41 104 181 242 379 |
Singh02 20 | Clusters | 13 41 104 181 242 379 |
Singh02 22 | Clusters | 83 114 151 |
Singh02 23 | Clusters | 104 181 242 379 |
Singh02 26 | Clusters | 129 |
Singh02 2 | Clusters | 13 41 104 181 242 379 |
Singh02 30 | Clusters | 383 441 |
Singh02 35 | Clusters | 204 |
Singh02 38 | Clusters | 83 114 151 |
Singh02 3 | Clusters | 13 41 104 181 242 379 |
Singh02 42 | Clusters | 7 41 104 181 242 379 |
Singh02 43 | Clusters | 204 |
Singh02 46 | Clusters | 204 |
Singh02 5 | Clusters | 13 41 104 181 242 379 |
Singh02 6 | Clusters | 104 181 242 379 |
Singh02 9 | Clusters | 36 |
single-stranded DNA binding | GO | 281 371 |
skeletal development | GO | 234 |
small molecule transport | GO | 415 |
small monomeric GTPase activity | GO | 86 |
small nuclear ribonucleoprotein | GO | 388 |
small nucleolar ribonucleoprotein complex | GO | 388 |
small protein conjugating enzyme activity | GO | 4 82 |
small ribosomal subunit | GO | 29 83 114 151 |
sodium ion transporter activity | GO | 22 62 152 |
Sorlie01 16 | Clusters | 239 |
Sorlie01 19 | Clusters | 453 |
Sorlie01 20 | Clusters | 84 |
Sorlie01 28 | Clusters | 453 |
Sorlie01 2 | Clusters | 285 366 453 |
Sorlie01 30 | Clusters | 567 |
Sorlie01 33 | Clusters | 54 |
Sorlie01 34 | Clusters | 285 366 453 |
Sorlie01 37 | Clusters | 239 |
Sorlie01 40 | Clusters | 284 366 453 |
Sorlie01 43 | Clusters | 206 389 |
Sorlie01 48 | Clusters | 47 |
Sorlie01 49 | Clusters | 342 |
Sorlie01 5 | Clusters | 284 366 453 |
Sorlie01 7 | Clusters | 26 207 389 |
Sorlie01 9 | Clusters | 207 389 |
S phase of mitotic cell cycle | GO | 125 158 |
sphingolipid catabolism | GO | 260 346 408 491 568 |
Spinal_cord_1 | Tissue | 12 |
Spinal_cord_2 | Tissue | 12 |
spindle | GO | 315 |
Spleen | Tissue | 84 |
spliceosome complex | GO | 388 |
Staunton01 11 | Clusters | 571 |
Staunton01 12 | Clusters | 213 |
Staunton01 15 | Clusters | 112 176 |
Staunton01 16 | Clusters | 470 557 |
Staunton01 18 | Clusters | 213 |
Staunton01 19 | Clusters | 372 441 |
Staunton01 26 | Clusters | 511 |
Staunton01 34 | Clusters | 213 |
Staunton01 38 | Clusters | 59 |
Staunton01 3 | Clusters | 112 176 |
Staunton01 40 | Clusters | 83 114 151 |
Staunton01 41 | Clusters | 213 |
Staunton01 42 | Clusters | 501 |
Staunton01 44 | Clusters | 213 |
Staunton01 45 | Clusters | 59 |
Staunton01 46 | Clusters | 213 |
Staunton01 48 | Clusters | 512 |
Staunton01 49 | Clusters | 242 379 |
Staunton01 4 | Clusters | 383 441 |
steroid binding | GO | 404 |
Sterol_biosynthesis | KEGG | 432 |
striated muscle contraction | GO | 201 329 387 512 |
striated muscle thick filament | GO | 201 329 387 512 |
structural constituent of muscle | GO | 201 329 387 512 |
structural constituent of ribosome | GO | 83 114 151 |
sugar binding | GO | 96 410 |
sulfur amino acid biosynthesis | GO | 354 |
sulfur amino acid catabolism | GO | 428 471 528 |
sulfur metabolism | GO | 235 |
symporter activity | GO | 218 368 511 |
synaptic transmission | GO | 274 379 |
synaptic vesicle | GO | 381 498 |
taxis | GO | 108 263 |
TCA Cycle | GenMapp | 306 |
T-cell activation | GO | 121 223 |
Terpenoid_biosynthesis | KEGG | 509 |
Testis_1 | Tissue | 72 |
Testis_2 | Tissue | 72 |
Thalamus_1 | Tissue | 11 66 100 137 |
Thalamus_2 | Tissue | 11 66 100 137 |
thermoregulation | GO | 76 |
THY-_1 | Tissue | 15 53 118 |
THY-_2 | Tissue | 15 53 118 |
Thymus_1 | Tissue | 44 84 |
Thymus_2 | Tissue | 44 84 |
THY+ | Tissue | 53 118 |
Trachea_1 | Tissue | 6 |
Trachea_2 | Tissue | 6 |
transcription\, DNA-dependent | Tissue | 124 |
transcription factor activity | GO | 372 441 |
transcription from Pol II promoter | GO | 308 |
transcription from Pol I promoter | GO | 331 |
transcription | GO | 124 |
transcription regulator activity | GO | 198 252 |
transferase activity\, transferring acyl groups | Tissue | 249 377 |
transferase activity\, transferring glycosyl groups | Tissue | 377 |
transferase activity\, transferring groups other than amino-acyl groups | Tissue | 249 377 |
transferase activity\, transferring one-carbon groups | Tissue | 349 |
transferase activity\, transferring pentosyl groups | Tissue | 377 |
transition metal ion binding | GO | 280 371 |
transition metal ion homeostasis | GO | 540 |
translational elongation | GO | 150 |
translational initiation | GO | 81 115 149 |
translation elongation factor activity | GO | 150 |
translation factor activity\, nucleic acid binding | Tissue | 159 |
Translation Factors | GenMapp | 115 149 |
translation initiation factor activity | GO | 81 115 149 |
translation regulator activity | GO | 159 |
translation release factor activity | GO | 87 |
transmembrane receptor activity | GO | 27 64 |
transmembrane receptor protein kinase activity | GO | 85 199 259 |
transmembrane receptor protein phosphatase activity | GO | 498 |
transmembrane receptor protein tyrosine kinase activity | GO | 85 199 259 |
transmembrane receptor protein tyrosine kinase signaling pathway | GO | 200 259 |
transmission of nerve impulse | GO | 379 |
tricarboxylic acid cycle | GO | 377 |
tRNA ligase activity | GO | 35 110 160 |
trypsin activity | GO | 109 |
tumor necrosis factor receptor binding | GO | 426 |
two-component signal transduction system (phosphorelay) | GO | 173 407 465 560 |
Tyrosine_metabolism | KEGG | 373 |
ubiquinol-cytochrome c reductase activity | GO | 149 |
Ubiquinone_biosynthesis | KEGG | 77 152 |
ubiquitin conjugating enzyme activity | GO | 4 82 |
ubiquitin cycle | GO | 82 |
Urea_cycle_and_metabolism_of_amino_groups | KEGG | 440 |
vacuolar hydrogen-transporting ATPase | GO | 307 |
vesicle coat | GO | 39 264 395 509 |
vesicle-mediated transport | GO | 274 379 |
vesicle membrane | GO | 381 498 |
viral genome | GO | 89 203 552 |
viral host cell process manipulation | GO | 403 451 |
viral host defense evasion | GO | 254 312 439 |
virion | GO | 89 203 552 |
vision | GO | 287 373 |
vitamin binding | GO | 404 |
voltage-gated ion channel activity | GO | 383 441 |
voltage-gated potassium channel complex | GO | 498 |
Whitfield02 15 | Clusters | 163 |
Whitfield02 20 | Clusters | 239 |
Whitfield02 22 | Clusters | 95 163 |
Whitfield02 34 | Clusters | 54 |
Whitfield02 45 | Clusters | 323 |
Whitfield02 46 | Clusters | 95 163 |
Whitfield02 49 | Clusters | 9 48 95 163 |
Whitfield02 8 | Clusters | 486 |
Whitfield02 9 | Clusters | 212 |
Whole_Blood_1 | Tissue | 45 84 |
Whole_Blood_2 | Tissue | 45 84 |
Whole_Blood_3 | Tissue | 45 84 |
Whole_Blood_4 | Tissue | 45 84 |
Whole_Blood_5 | Tissue | 45 84 |
Whole_Blood_6 | Tissue | 45 84 |
Whole_Brain_1 | Tissue | 11 66 100 137 |
Whole_Brain_2 | Tissue | 11 66 100 137 |
WSU_1 | Tissue | 53 118 |
WSU_2 | Tissue | 53 118 |
xenobiotic metabolism | GO | 247 |
zinc ion binding | GO | 280 371 |